Pharmaceutical company Novartis is laying off more than 400 US employees who report to its East Hanover facility as part of a ...
1d
Zacks Investment Research on MSNAlnylam Gets FDA Nod for Expanded Use of Amvuttra in CardiomyopathyAlnylam Pharmaceuticals ALNY announced that the FDA had approved its regulatory filing seeking the label expansion of its ...
Swiss pharma major Novartis (NOVN: VX) is set to lay off 427 employees at its East Hanover, New Jersey, site as part of a ...
The PBM plans to stop requiring coverage authorization for about 80 drugs, including Vertex’s cystic fibrosis medicines and ...
The massive pharmacy benefit manager plans to stop requiring coverage authorizations for roughly 80 drugs used to treat ...
Novartis said that the latest round of job losses is a result of a change in focus for its cardiovascular teams as they lower the emphasis on Entresto and devote more resources to its twice-yearly ...
Novartis Pharmaceuticals is removing hundreds of New Jersey employees from its company. The global drugmaker will lay off 427 ...
The notice comes three months after the pharmaceutical giant said it would eliminate 139 jobs at the location between February and August.
Even as Novartis takes home a partial win in court tied to its key blockbuster Entresto, the Swiss drugmaker continues to ...
Global drugmaker Novartis will lay off 427 employees in East Hanover this spring and summer, after it let go of 235 at the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results